Study open

HPV

Human papillomavirus (HPV) is a common virus that can infect the skin and mucous membranes. This infection occurs primarily through sexual contact. More than 200 different types of HPV are known to affect both men and women. These types can manifest in various locations such as the genitals, anus, skin and mouth.

Symptoms and risks of HPV

The symptoms of HPV infection vary widely. Some experience genital warts, while others show no obvious symptoms. However, some HPV types can cause severe cellular changes that can lead to cancer. For example, HPV-16 is one of the riskiest types and is responsible for a large proportion of cervical cancer cases. Moreover, this type also plays a role in the development of head and neck cancers, including cancers in the throat, tongue root and tonsils.

The prevalence of HPV in Belgium

In Belgium, about 80% of the sexually active population experiences HPV infection at some point in their lives. This rate is especially high among young people between the ages of 15 and 24. This wide spread underscores the importance of preventive measures such as vaccination and regular medical screenings.

Vaccination: a crucial preventive measure

There are currently two vaccines available that offer protection against different types of HPV. These vaccines are strongly recommended for girls between the ages of 12 and 16. This is because vaccination is most effective before sexual activity and possible exposure to the virus has occurred.

But the problem is not limited to women. HPV can also cause cancer in men, especially oropharyngeal cancers in the throat, tongue root and tonsils. In Belgium, therefore, vaccination of boys began in 2019. The Netherlands followed suit in 2022. Vaccination of both boys and girls is essential to limit the spread of the virus and prevent related cancers.

The role of research and screenings

Recent research increasingly focuses on the importance of HPV vaccination for both sexes. The Supreme Health Council therefore recommends vaccination at an early age for both boys and girls. In addition to vaccination, regular screenings remain of great importance for the early detection and treatment of HPV-related complications. For example, these screenings can detect abnormal cells at an early stage, increasing the likelihood of successful treatment.

Your contribution to the study

We are launching a new study focused on the effectiveness of a vaccine to protect both women and men from HPV. Would you like to contribute to this important research and thereby help in the fight against HPV-related cancers? Then get in touch with us. Together, we can work toward a future in which these cancers are significantly reduced.